Use of Preventive Measures for Cardiovascular Disease in People With HIV - Summary - MDSpire

Use of Preventive Measures for Cardiovascular Disease in People With HIV

  • By

  • Nadine Jaschinski

  • Bastian Neesgaard

  • Ferdinand Wit

  • Marc Van der Valk

  • Justyna Kowalska

  • Anna Lisa Ridolfo

  • Huldrych F Günthard

  • Marcel Stöckle

  • Elmar Wallner

  • Piotr Nowak

  • Antonella Castagna

  • Antonella d’Arminio Monforte

  • Kathy Petoumenos

  • Jennifer F Hoy

  • Sean Hosein

  • Jens Lundgren

  • Harmony Garges

  • Felipe Rogatto

  • Lital Young

  • Lars Peters

  • Amanda Mocroft

  • Lene Ryom

  • on behalf of the

  • RESPOND Study Group

  • F Wit

  • M van der Valk

  • M Hillebregt

  • K Petoumenos

  • M Law

  • J Hutchinson

  • W Min Han

  • D Rupasinghe

  • R Zangerle

  • H Appoyer

  • J Vera

  • A Clarke

  • B Broster

  • L Barbour

  • D Carney

  • L Greenland

  • R Coughlan

  • S De Wit

  • M Delforge

  • J Begovac

  • J Kowalska

  • C Stephan

  • M Bucht

  • N Chkhartishvili

  • O Chokoshvili

  • A d’Arminio Monforte

  • A Rodano

  • A Tavelli

  • I Fanti

  • C Mussini

  • V Borghi

  • M Menozzi

  • A Cervo

  • C Pradier

  • E Fontas

  • K Dollet

  • C Caissotti

  • J Casabona

  • J M Miro

  • F Burns

  • C Smith

  • F Lampe

  • C Chaloner

  • A Castagna

  • A Lazzarin

  • R Lolatto

  • A Sönnerborg

  • C Carlander

  • P Nowal

  • J Vesterbacka

  • D Carrick

  • K Stigsäter

  • L Mattson

  • H Günthard

  • K Kusejko

  • J C Wasmuth

  • J Rockstroh

  • J J Vehreschild

  • G Fätkenheuer

  • M Scherer

  • G Sauer

  • N Schulze

  • L Ryom*

  • M Law*

  • R Campo

  • S De Wit

  • H Garges

  • H Günthard

  • J Lundgren

  • F Bognar

  • J Rooney

  • C Mussini

  • V Vannappagari

  • G Wandeler

  • L Young

  • R Zangerle

  • J Lundgren

  • H Günthard

  • J Begovac

  • F Burns

  • A Castagna

  • R Campo

  • N Chkhartishvili

  • A D’Arminio Monforte

  • N Dedes

  • M Dunbar

  • H Garges

  • J Kowalska

  • M Law

  • C Mussini

  • C Necsoi

  • L Peters

  • K Petoumenos

  • C Pradier

  • D Raben

  • J Rockstroh

  • J Rooney

  • L Ryom

  • A Sönnerborg

  • V Vannappagari

  • J J Vehreschild

  • A Volny-Anne

  • J C Wasmuth

  • E D Williams

  • F Wit

  • L Young

  • R Zangerle

  • L Ryom

  • B Neesgaard

  • L Greenberg

  • N Jaschinski

  • A Timiryasova

  • L Bansi-Matharu

  • D Raben

  • L Peters

  • E Tusch

  • W Bannister

  • A Roen

  • D Byonanebye

  • O Fursa

  • A Pelchen-Matthews

  • J Reekie

  • V Svedhem-Johansson

  • M Van der Valk

  • F Wit

  • K Grabmeier-Pfistershammer

  • R Zangerle

  • J Hoy

  • M Bloch

  • D Braun

  • A Calmy

  • G Schüttfort

  • M Youle

  • S De Wit

  • C Mussini

  • S Zona

  • A Castagna

  • A Antinori

  • N Chkhartishvili

  • N Bolokadze

  • E Fontas

  • K Dollet

  • C Pradier

  • J M Miro

  • J M Llibre

  • J J Vehreschild

  • C Schwarze-Zander

  • J C Wasmuth

  • J Rockstroh

  • K Petoumenos

  • J Hutchinson

  • M Law

  • J Begovac

  • C Duvivier

  • G Dragovic

  • R Radoi

  • C Oprea

  • M Vasylyev

  • J Kowalska

  • R Matulionyte

  • V Mulabdic

  • G Marchetti

  • E Kuzovatova

  • N Coppola

  • I Aho

  • S Martini

  • H Bucher

  • A Harxhi

  • T Wæhre

  • A Pharris

  • A Vassilenko

  • G Fätkenheuer

  • J Bogner

  • A Maagaard

  • E Jablonowska

  • D Elbirt

  • G Marrone

  • C Leen

  • C Wyen

  • L Dahlerup Rasmussen

  • C Hatleberg

  • C Carlander

  • F Burns

  • M Kundro

  • N Dedes

  • E Dixon Williams

  • J Gallant

  • C Cohen

  • M Dunbar

  • A Marongiu

  • V Vannappagari

  • H Garges

  • R Campo

  • L Young

  • A Abutidze

  • I Aho

  • J Begovac

  • L Dahlerup Rasmussen

  • R Campo

  • M Dunbar

  • A Ekström

  • O Elvstam

  • O Fursa

  • C Hatleberg

  • J Gallant

  • H Garges

  • J Gruber

  • H Günthard

  • J Hosein

  • J Hoy

  • O Kirk

  • M Law

  • N Jaschinski

  • A Marongiu

  • B Neesgaard

  • L Peters

  • K Petoumenos

  • J Rooney

  • L Ryom

  • A Sönnerborg

  • A Timiryasova

  • M Van der Valk

  • V Vannappagari

  • J Vehreschild

  • A Weibull Wärnberg

  • F Wit

  • X Xu

  • L Young

  • R Zangerle

  • A Volny-Anne

  • N Dedes

  • L Mendão

  • E Dixon Williams

  • N Jaschinski

  • B Neesgaard

  • A Timiryasova

  • O Fursa

  • L Ryom

  • O Valdenmaier

  • J F Larsen

  • M Gardizi

  • D Raben

  • T W Elsing

  • L Ramesh Kumar

  • B Pepa

  • L Peters

  • L Greenberg

  • K Petoumenos

  • J Hutchinson

  • E Tusch

  • W Bannister

  • W Min Han

  • September 24, 2025

  • 0 min

Share

Objective:

To determine the annual prevalence of cardiovascular disease (CVD) preventive measures among individuals with HIV at very high estimated 10-year CVD risk from 2012 to 2021, focusing on the implications of these measures.

Key Findings:
  • The proportion of individuals with >10% estimated 10-year CVD risk increased from 32.4% to 52.1% between 2012 and 2021.
  • 67.4% of individuals with hypertension used antihypertensives, 55.9% with dyslipidemia used lipid-lowering drugs, and only 7.4% of smokers ceased smoking.
  • A decline in the use of antidiabetics was observed among individuals with diabetes over time, from 60.3% to 57.2%.
  • Men ≥40 years and women ≥50 years were more likely to use various preventive measures.
Interpretation:

Despite an increasing number of individuals at very high CVD risk, the uptake of preventive measures remained suboptimal, underscoring the urgent need for improved awareness and management strategies in clinical care for people with HIV.

Limitations:
  • Limited data on the effectiveness of specific preventive measures.
  • Potential bias from missing data despite efforts to include only cohorts with high data completeness.
  • Findings may not be generalizable beyond the RESPOND cohort.
Conclusion:

The findings highlight the urgent need for enhanced CVD risk management strategies among individuals living with HIV, particularly as the population ages and CVD risk increases.

Original Source(s)

Use of Preventive Measures for Cardiovascular Disease in People With HIV

  • by Nadine Jaschinski, Bastian Neesgaard, Ferdinand Wit, Marc Van der Valk, Justyna Kowalska, Anna Lisa Ridolfo, Huldrych F Günthard, Marcel Stöckle, Elmar Wallner, Piotr Nowak, Antonella Castagna, Antonella d’Arminio Monforte, Kathy Petoumenos, Jennifer F Hoy, Sean Hosein, Jens Lundgren, Harmony Garges, Felipe Rogatto, Lital Young, Lars Peters, Amanda Mocroft, Lene Ryom, on behalf of the, RESPOND Study Group, F Wit, M van der Valk, M Hillebregt, K Petoumenos, M Law, J Hutchinson, W Min Han, D Rupasinghe, R Zangerle, H Appoyer, J Vera, A Clarke, B Broster, L Barbour, D Carney, L Greenland, R Coughlan, S De Wit, M Delforge, J Begovac, J Kowalska, C Stephan, M Bucht, N Chkhartishvili, O Chokoshvili, A d’Arminio Monforte, A Rodano, A Tavelli, I Fanti, C Mussini, V Borghi, M Menozzi, A Cervo, C Pradier, E Fontas, K Dollet, C Caissotti, J Casabona, J M Miro, F Burns, C Smith, F Lampe, C Chaloner, A Castagna, A Lazzarin, R Lolatto, A Sönnerborg, C Carlander, P Nowal, J Vesterbacka, D Carrick, K Stigsäter, L Mattson, H Günthard, K Kusejko, J C Wasmuth, J Rockstroh, J J Vehreschild, G Fätkenheuer, M Scherer, G Sauer, N Schulze, L Ryom*, M Law*, R Campo, S De Wit, H Garges, H Günthard, J Lundgren, F Bognar, J Rooney, C Mussini, V Vannappagari, G Wandeler, L Young, R Zangerle, J Lundgren, H Günthard, J Begovac, F Burns, A Castagna, R Campo, N Chkhartishvili, A D’Arminio Monforte, N Dedes, M Dunbar, H Garges, J Kowalska, M Law, C Mussini, C Necsoi, L Peters, K Petoumenos, C Pradier, D Raben, J Rockstroh, J Rooney, L Ryom, A Sönnerborg, V Vannappagari, J J Vehreschild, A Volny-Anne, J C Wasmuth, E D Williams, F Wit, L Young, R Zangerle, L Ryom, B Neesgaard, L Greenberg, N Jaschinski, A Timiryasova, L Bansi-Matharu, D Raben, L Peters, E Tusch, W Bannister, A Roen, D Byonanebye, O Fursa, A Pelchen-Matthews, J Reekie, V Svedhem-Johansson, M Van der Valk, F Wit, K Grabmeier-Pfistershammer, R Zangerle, J Hoy, M Bloch, D Braun, A Calmy, G Schüttfort, M Youle, S De Wit, C Mussini, S Zona, A Castagna, A Antinori, N Chkhartishvili, N Bolokadze, E Fontas, K Dollet, C Pradier, J M Miro, J M Llibre, J J Vehreschild, C Schwarze-Zander, J C Wasmuth, J Rockstroh, K Petoumenos, J Hutchinson, M Law, J Begovac, C Duvivier, G Dragovic, R Radoi, C Oprea, M Vasylyev, J Kowalska, R Matulionyte, V Mulabdic, G Marchetti, E Kuzovatova, N Coppola, I Aho, S Martini, H Bucher, A Harxhi, T Wæhre, A Pharris, A Vassilenko, G Fätkenheuer, J Bogner, A Maagaard, E Jablonowska, D Elbirt, G Marrone, C Leen, C Wyen, L Dahlerup Rasmussen, C Hatleberg, C Carlander, F Burns, M Kundro, N Dedes, E Dixon Williams, J Gallant, C Cohen, M Dunbar, A Marongiu, V Vannappagari, H Garges, R Campo, L Young, A Abutidze, I Aho, J Begovac, L Dahlerup Rasmussen, R Campo, M Dunbar, A Ekström, O Elvstam, O Fursa, C Hatleberg, J Gallant, H Garges, J Gruber, H Günthard, J Hosein, J Hoy, O Kirk, M Law, N Jaschinski, A Marongiu, B Neesgaard, L Peters, K Petoumenos, J Rooney, L Ryom, A Sönnerborg, A Timiryasova, M Van der Valk, V Vannappagari, J Vehreschild, A Weibull Wärnberg, F Wit, X Xu, L Young, R Zangerle, A Volny-Anne, N Dedes, L Mendão, E Dixon Williams, N Jaschinski, B Neesgaard, A Timiryasova, O Fursa, L Ryom, O Valdenmaier, J F Larsen, M Gardizi, D Raben, T W Elsing, L Ramesh Kumar, B Pepa, L Peters, L Greenberg, K Petoumenos, J Hutchinson, E Tusch, W Bannister, W Min Han

  • September 24, 2025

Related Content

Long COVID May Raise Cardiovascular Risk

Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.

Why Younger Adults Need to Be Tested, Treated for Unhealthy Cholesterol Levels

Unhealthy levels of cholesterol have long been viewed as a condition that primarily affects older adults

  • by

  • March 31, 2026

  • 9 min
Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on changes in ambulatory blood pressure: a sub-analysis of a randomized clinical trial